An Open-label Continuation Study Evaluating the Long-term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s Disease

Status:
Completed

Trial end date:
2010-03-01

Target enrollment:

Participant gender:

To evaluate the safety profile of ropinirole XL during long-term treatment in subjects with early and advanced Parkinson's disease

Phase 3

GlaxoSmithKline

Ropinirole